Perigon Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3M | Sell |
5,716
-1,432
| -20% | -$752K | 0.07% | 263 |
|
|
2025
Q1 | $4.53M | Sell |
7,148
-17
| -0.2% | -$10.8K | 0.12% | 176 |
|
|
2024
Q4 | $4.97M | Sell |
7,165
-1,396
| -16% | -$968K | 0.12% | 161 |
|
|
2024
Q3 | $9M | Buy |
8,561
+242
| +3% | +$254K | 0.24% | 89 |
|
|
2024
Q2 | $8.74M | Buy |
8,319
+239
| +3% | +$251K | 0.25% | 80 |
|
|
2024
Q1 | $7.78M | Buy |
8,080
+1,968
| +32% | +$1.89M | 0.24% | 96 |
|
|
2023
Q4 | $5.37M | Buy |
6,112
+161
| +3% | +$141K | 0.18% | 123 |
|
|
2023
Q3 | $4.9M | Buy |
5,951
+560
| +10% | +$461K | 0.2% | 112 |
|
|
2023
Q2 | $3.87M | Buy |
5,391
+320
| +6% | +$230K | 0.15% | 139 |
|
|
2023
Q1 | $4.17M | Buy |
5,071
+240
| +5% | +$197K | 0.24% | 97 |
|
|
2022
Q4 | $3.49M | Buy |
4,831
+386
| +9% | +$278K | 0.22% | 109 |
|
|
2022
Q3 | $3.06M | Buy |
4,445
+1,205
| +37% | +$830K | 0.26% | 81 |
|
|
2022
Q2 | $1.92M | Buy |
3,240
+149
| +5% | +$88.1K | 0.16% | 131 |
|
|
2022
Q1 | $2.16M | Sell |
3,091
-430
| -12% | -$300K | 0.15% | 126 |
|
|
2021
Q4 | $2.22M | Buy |
3,521
+13
| +0.4% | +$8.21K | 0.16% | 122 |
|
|
2021
Q3 | $2.12M | Buy |
3,508
+37
| +1% | +$22.4K | 0.18% | 109 |
|
|
2021
Q2 | $1.94M | Buy |
3,471
+15
| +0.4% | +$8.38K | 0.17% | 115 |
|
|
2021
Q1 | $1.64M | Buy |
3,456
+2,122
| +159% | +$1M | 0.17% | 120 |
|
|
2020
Q4 | $644K | Sell |
1,334
-86
| -6% | -$41.5K | 0.07% | 207 |
|
|
2020
Q3 | $795K | Buy |
1,420
+85
| +6% | +$47.6K | 0.11% | 151 |
|
|
2020
Q2 | $833K | Sell |
1,335
-1
| -0.1% | -$624 | 0.13% | 127 |
|
|
2020
Q1 | $685K | Buy |
1,336
+581
| +77% | +$298K | 0.13% | 133 |
|
|
2019
Q4 | $281K | Sell |
755
-2
| -0.3% | -$744 | 0.06% | 207 |
|
|
2019
Q3 | $230K | Hold |
757
| – | – | 0.05% | 209 |
|
|
2019
Q2 | $237K | Buy |
757
+50
| +7% | +$15.7K | 0.06% | 207 |
|
|
2019
Q1 | $247K | Buy |
707
+47
| +7% | +$16.4K | 0.06% | 187 |
|
|
2018
Q4 | $276K | Sell |
660
-52
| -7% | -$21.7K | 0.07% | 170 |
|
|
2018
Q3 | $288K | Sell |
712
-158
| -18% | -$63.9K | 0.07% | 179 |
|
|
2018
Q2 | $300K | Buy |
870
+808
| +1,303% | +$279K | 0.09% | 181 |
|
|
2018
Q1 | $21K | Buy |
+62
| New | +$21K | 0.01% | 432 |
|
|
2017
Q4 | – | Sell |
-464
| Closed | -$207K | – | 664 |
|
|
2017
Q3 | $207K | Sell |
464
-949
| -67% | -$423K | 0.07% | 197 |
|
|
2017
Q2 | $694K | Buy |
1,413
+54
| +4% | +$26.5K | 0.15% | 147 |
|
|
2017
Q1 | $527K | Buy |
1,359
+70
| +5% | +$27.1K | 0.11% | 171 |
|
|
2016
Q4 | $488K | Buy |
1,289
+248
| +24% | +$93.9K | 0.11% | 177 |
|
|
2016
Q3 | $419K | Sell |
1,041
-14
| -1% | -$5.64K | 0.11% | 157 |
|
|
2016
Q2 | $368K | Buy |
+1,055
| New | +$368K | 0.1% | 159 |
|